The application of monoclonal antibodies to the diagnosis of disseminated mycoses

Revista Iberoamericana de Micologia

Volumn 15, Issue 3, 1998, Pages 118-124

  Hamilton, Andrew John ^a   Gómez, Beatriz Lucía ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b Unidad de Biología Celular y Molecular   (Colombia)

Author keywords

Diagnosis; Fungal pathogens; Monoclonal antibodies

Indexed keywords

EID: 2742521538     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (129)

1. DeRepentigny L, Reiss E Current trends in immunodiagnosis of candidiasis and aspergillosis Rev Infect Dis 1984;6:301-312.
2. Hearn VM. Serodiagnosis of aspergillosis. In: Vanden Bossche H, Mackenzie DWR, Cauwenbergh G (Eds) Aspergillus, Aspergillosis. New York, Plenum, 1988, 43-71
3. Hamilton AJ, Holdom MD, Hay RJ. Specific recognition of purified Cu, Zn superoxide dismutase from Aspergillus fumigatus by immune human sera. J Clin Microbiol 1995;33:495-496.
4. Burnie JP, Matthews RC. Heat shock protein 88 and Aspergillus infection. J Clin Microbiol 1991:29:2099-2106.
5. Fratamico PM, Buckley HR. Identification and characterization of an immunodominent 58-kilodalton antigen of Aspergillus fumigatus recognized by sera of patients with invasive aspergillosis. Infect Immun 1991;59:309-315
6. Reiss E, Lehmann PF. Galactomannan antigenemia in invasive aspergillosis Infect Immun 1979;25:357-365
7. Latge JP. Tools and trends in the detection of Aspergillus fumigatus. Curr Top Med Mycol 1995:6:245-281.
8. Schaffer PJ, Medoff G, Kobayashi GS. Demonstration of antigenemia in patients with invasive aspergillosis by solid phase (protein A-rich Staphylococcus aureus) radioimmunoassay. Am J Med 1979;67:627-630.
9. Weiner MH, Coats-Stephen M. Immunodiagnosis of systemic aspergillosis I: antigenemia detected by radioimmunoassay in experimental infection. J Lab Clin Med 1979;93:111-119.
10. Johnson TM, Kurup VP, Resnick A, Ash RC, Fink JN, Kalbfleisch J. Detection of circulating Aspergillus fumigatus antigen in bone marrow transplant patients. J Lab Clin Med 1989;114:700-707.
11. Rogers TR, Haynes KA, Barnes RA. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990;336:1210-1213.
12. Stynen D, Sarfati J, Goris A, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992;60:2237-2245.
13. Dupont B, Improvisi L, Provost F. Detection de galactomannane dans les aspergilloses invasives humaines et animales avec un test au latex. Bull Soc Fr Mycol Med 1990;19:35-42.
14. Haynes KA, Rogers TR. Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1994; 13:670-674.
15. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500
16. Sulahian A, Tabouret M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactqmannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996;15:139-145.
17. Verweij PE, Stynen D, Rijs AJJM, et al Sandwich enzyme linked-immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33:1912-1914.
18. Rohrlich P, Sarfati J, Mariani P et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan. early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-237.
19. Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AVMB, Meis JGFM. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997; 25:86-89
20. Verweij PE, Latge JP, Rijs AJMM, et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995;33:3150-3153
21. Swanink CMA, Meis JFGM, Rijs AJMM, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257-260.
22. Lamy B, Davies J Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleqlytic toxin restrictocin and its expression in A nidulans: the leader sequence protects producing strains from suicide. Nucl Acids Res 1991;19:1001-1006
23. Lamy B, Moutaouakil M, Latge JP, Davies J. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during aspergillosis infections. Mol Microbiol 1991;5:1811-1815.
24. Arrese Estrada J, Stynen D, Goris A, Pierard GE. Immunohistochemical identification of Aspergillus by monoclonal antibody EB-A1. Ann Pathol 1990;10:198-200.
25. Jensen HE, Aalbaek B, Lind P, Frandsen PL, Krogh HV, Stynen D. Enzyme immunohistochemistry with mono- and polyclonal antibodies in the pathological diagnosis of systemic bovine mycoses. APMIS 1993;101:505-516
26. Verweij PE, Smedts F, Poot T, et al Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections. J Clin Pathol 1996;49:789-801
27. Gutierrez J, Maroto C, Piedrola G, Martin E, Perez JA. Circulating Candida antigens and antibodies: useful markers of candidemia. J Clin Microbiol 1993;31:2550-2552.
28. Kappe R, Seeliger HPR. Serodiagnosis of deep-seated fungal infections. Curr Top Med Mycol 1993;5:247-280.
29. Kobayashi K, Mukae N, Matsunaga Y, Hotchi M Diagnostic value of serum antibody to Candida in an extensively burned patient. Burns 1990;16:414-417.
30. Zoller L, Kramer I, Kappe R, Sonntag HG. Enzyme immunoassays for invasive Candida infections: reactivity of somatic antigens of Candida albicans. J Clin Microbiol 1991;29:1860-1867.
31. Garcia-Ruiz JC, Arilla MC, Regulez P, Quindos G, Alvarez A, Ponton J. Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with haematological malignancies. J Clin Microbiol 1997;35:3284-3287.
32. Franklyn KM, Warmington JR, Ott AK, Ashman RB. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase Immunol Cell Biol 1990;68:173-178
33. Walsh TJ, Hathorn JW, Sobel JD, et al. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991;324:1026-1031
34. van Deventer AJ, van Vliet HJ, Hop WC, Goessens WH Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol 1994;32:17-23.
35. Sundstrom PM, Tam MR, Nichols EJ, Kenny GE. Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies. Infect Immun 1988;56:601-606.
36. Stockbine NA, Largen MT, Buckley HR. Production and characterisation of three monoclonal antibodies to Candida albicans proteins. Infect Immun 1984;43:1012-1018.
37. De Repentigny L, Kaufman L, Cole GT, Kruse D, Latge JP, Mathews RC. immunodiagnosis of invasive fungal infections. J Med Vet Mycol 1994;32 (Suppl 1): 239-252
38. Buckley HR, Richardson MD, Evans EGV, Wheat LJ Immunodiagnosis of invasive fungal infections. J Med Vet Mycol 1992;30 (Suppl.):249-260.
39. Herent P, Stynen D, Hernando F, Fruit J, Poulain D. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. J Clin Microbiol 1992;30:2158-2164.
40. Mitsutake K, Miyazaki T, Tashiro T, et al. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J Clin Microbiol 1996;34:1918-1921
41. Borg M, Watters D, Reich B, Ruchel R. Production and characterization of monoclonal antibodies against secretory proteinase of Candida albicans CBS 2730. Zentralbl Baktenol Mikrobiol Hyg A 1988;268:62-71.
42. Ruchel R. Proteinase. In: Bennett JE, Hay RJ, Peterson PK (Eds) New strategies in fungal diseases. Edinburgh, Churchill-Livingstone, 1992:17-31.
43. DeBernardis F, Girmenia C, Boccanera M, Adriani D, Martino P, Cassone A. Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis. J Clin Microbiol 1993;31:3142-3146.
44. Fung JC, Donta ST, Tilton RC. Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease. J Clin Microbiol 1986;24:542-547.
45. Phillips P, Dowd A, Jewesson P, et al. Nonvalue of antigen detection immunoassay for diagnosis for candidemia. J Clin Microbiol 1990; 28:2320-2326.
46. Obayashi T, Yoshida M, Mori T, et al. Plasma (1-3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes Lancet 1994;345:17-20.
47. Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (1-3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995;33:3115-3118.
48. Jensen HE, Schønheyder HC, Hotchi M, Kaufman L. Diagnosis of systemic mycoses by specific immunohistochemical tests. APMIS 1996;104:241-258.
49. Hopwood V, Poulain D, Fortier B, Evans G, Vernes A. A monoclonal antibody to a cell wall component of Candida albicans. Infect Immun 1986; 54:222-227.
50. Cailliez JC, Boudrissa A, Mackenzie DWR, Poulain D Evaluation of a gold-silver staining method for detection and identification of Candida species by light microscopy. Eur J Clin Microbiol Infect Dis 1990; 9:886-891.
51. Breier F, Oesterreicher C, Brugger S, Linkesch W, Anegg B, Jurecka W. Immunohistochemistry with monoclonal antibody against Candida albicans mannan antigen demonstrates cutaneous Candida granulomas as evidence of Candida sepsis in an immunosuppressed host. Dermatology 1997; 194:293-296
52. Monteagudo C, Marcilla A, Mormeneo, Llombart-Bosch A, Sentandreu R. Specific immunohistochemical identification of Candida albicans in paraffin-embedded tissue with a new monoclonal antibody (1B12). Am J Clin Pathol 1995;103:130-135
53. Robert R, Sentandreu R, Bernard C, Senet J-M. Evaluation du réactif Biochrolatex albicans pour l'identification de colonies de Candida albicans. J Mycol Med 1994; 4:226-229.
54. Freydiere AM, Buchaille L, Guinet R, Gille Y. Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies. J Clin Microbiol 1997;35:877-880.
55. Eng RHK, Bishburg E, Smith SM, Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986;81:19-23
56. Chuck SL, Sande MA Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321:794-799.
57. Heelan JS, Corpus L, Kessimian N. False-positive reactions in the latex agglutination test for Cryptococcus neoformans antigen. J Clin Microbiol 1991; 29;1260-1261
58. Wu TC, Koo SY. Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen. J Clin Microbiol 1983; 18:1127-1130.
59. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986; 104:234-240.
60. Hay RJ, Mackenzie DWR. False-positive latex tests for cryptococcal antigen in cerebrospinal fluid. J Clin Microbiol 1982; 35:244-245.
61. Dromer F, Salamero J, Contrepois A, Carbon C, Yeni P. Productron,characterization and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun 1987;55:742-748
62. Todaro-Luck F, Reiss E, Cherniak R, Kaufman L. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun 1989;57:3882-3887
63. Temstet A, Roux P, Poirot JL, Ronin O, Dromer F. Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies. J Clin Microbiol 1992;30:2544-2550.
64. Kiska DL, Orkiszewski DR, Howell D, Gilligan PH. Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol 1994; 32;2309-2311.
65. Eckert TF, Kozel TR. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect Immun 1987;55:1895-1899.
66. Gade W, Hinnefeld SW, Babcock LS, et al. Comparison of the Premier cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol 1991;29:1616-1619.
67. Mukherjee S, Casadevall A. Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies. J Clin Microbiol 1995;33:765-768.
68. Hamilton AJ, Jeavons L Hobby P, Hay RJ. A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope. Infect Immun 1992; 60:143-149.
69. Hamilton AJ, Goodley J. Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera. J Clin Microbiol 1993;31.335-339.
70. Kaplan W, Bragg SL, Crane S, Ahearn DG. Serotyping Cryptococcus neoformans by immunofluorescence. J Clin Microbiol 1981; 14:313-317.
71. Klein BS, Kuntsky JN, Chapell WA, et al. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis Amer Rev Resp Dis 1986;133:144-148.
72. Klein BS, Vergeront JM, Kaufman L. et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin J Infect Dis 1987; 155:262-268.
73. Sekhon AS, Kaufman L, Kobayashi GS, Moledina NH, Jalbert M. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol 1995;33:123-125.
74. Bradsher RW. A clinician's view of blastomycosis Curr Top Med Mycol 1993;5:181-200.
75. Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis 1996;22,(Suppl. 2): S102-S111.
76. Klein BS, Jones JM. isolation, purification and radiolabelling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest 1990;85:152-161.
77. Lo CY, Notenboom RH. A new enzyme immunoassay specific for blastomycosis. Am Rev Respir Dis 1990; 141:84-88.
78. Areno JP, Campbell GD, George RB. Diagnosis of blastomyeosis. Sem Resp Infect 1997;12:252-262
79. Galgiani JN, Grace GM, Lundergan LL. New serologic tests for early detection of coccidioidomycosis. J Infect Dis 1991;163:671-674.
80. Martins TB, Jaskowski TD, Mouritsen CL, Hill HR. Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J Clin Microbiol 1995;33: 940-943
81. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990;3:247-268.
82. Yang MC, Magee DM, Cox RA. Mapping of a Coccidioides immitis-specific epitope that reacts with complement-fixing antibody. Infect Immun 1997;65:4068-4074.
83. Johnson SM, Zimmermann CR, Pappagianis D. Use of recombinant Coccidioides immitis complement fixation antigen-chitinase in conventional serological assays. J Clin Microbiol 1996;34:3160-3164
84. Zimmermann CR, Johnson SM, Martens GW, White AG, Pappagianis D. Cloning and expression of the complement fixation antigen-chitinase of Coccidioides immitis. Infect Immun 1996;64:4967-4975.
85. Zhu Y, Tryon V, Magee DM, Cox RA. Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes. Infect Immun 1997;65:3376-3380.
86. Dolan MJ, Cox RA, Williams V, Woolley S. Development and characterization of a monoclonal antibody against the tube precipitin antigen of Coccidioides immitis. Infect Immun 1989;57:1035-1039.
87. Cox RA, Dolan MJ, Magee DM, Galgiani JN. Production of a murine monoclonal antibody that recognises an epitope specific to Coccidioides immitis antigen 2. Infect Immun 1993;61:1895-1899.
88. Zhu Y, Yang C, Magee DM, Cox RA. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA. Infect Immun 1995;64:2695-2699.
89. Weiner MH. Antigenemia detected in human coccidioidomycosis. J Clin Microbiol 1983;18:136-142.
90. Galgiani JN, Dugger KO, Ito JI, Weiden MA. Antigenemia in primary coccidioidomycosis Am J Trop Med Hyg 1984;33:645-649.
91. Wack EE, Dugger KO, Galgiani JN. Enzyme-linked immunosorbent assay for antigens of Coccidioides immitis: human sera interference corrected by acidification-heat extraction. J Lab Clin Med 1988;111:560-565.
92. Davis BA. Sporotrichosis. Dermatol Clin 1996; 14:69-76.
93. Aram H. Sporotrichosis, a historical approach. Int J Dermatol 1986;25:203-205.
94. Winn RE A contemporary view of sporotrichosis. Curr Top Med Mycol 1995;6:73-94.
95. Kaufman L. Immunohistologic diagnosis of systemic mycoses: an update. Eur J Epidemiol 1992; 8:377-382.
96. Marques ME, Coelho KI, Sotto MN, Bacchi CE. Comparison between histochemical and immunohistachemical methods for diagnosis of sporotrichosis. J Clin Pathol 1992; 45:1089-1093.
97. Hamilton AJ, Harada T, Bartholomew MA, et al. Preparation of murine monoclonal antibodies against the yeast phase of the dimorphic fungus Sporothrix schenckii Trans Roy Soc Trop Med Hyg 1990; 84:734-737.
98. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996;23:125-130
99. Drouhet E. Penicilliosis due to Penicillium marneffer a new emerging systemic mycosis in AIDS patients travelling or living in Southeast Asia. Review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non AIDS patients reported over 20 years. J Mycol Med 1993;4:195-224.
100. Chongtrakool P, Chaiyaroj SC, Vithayasai V, et al. Immunoreactivity of a 38-kilodalton Penicillium marneffer antigen with human immunodeficiency virus-positive sera. J Clin Microbiol 1997;35:2220-2223.
101. Jeavons L, Hamilton AJ, Vanittanakom N, et al. Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera. J Clin Microbiol 1998;36:949-954.
102. Cao L, Chan CM, Lee C, Wong SS, Yuen KY. MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei. Infect Immun 1998;66:966-973.
103. Kaufman L, Standard PG, Jalbert M, et al. Diagnostic antigenemia tests for penicilliosis marneffei. J Clin Microbiol 1996;34:2503-2505.
104. Arrese Estrada J, Stynen D, Van Cutsem J, Pierard-Franchimont C, Pierard GE. Immunohistochemical identification of Pennicilium marneffei by monoclonal antibody. Intern J Dermatol 1992; 31:410-412.
105. Kaufman L, Standard PG, Anderson SA, et al. Development of specific fluorescentantibody test for tissue form of Pennicilium marneffei. J Clin Microbiol 1995;33:2136-2138.
106. Bullock WE. Histoplasma capsulatum. In: Mandell GL, Bennet J, Dolin M (Eds) Principles and practice of infectious diseases. New York, Churchill Livingstone, 1995: 2340-2353
107. Kwon-Chung KJ and Bennet JE. Histoplasmosis. In: Kwon-Chung KJ and Bennet JE (Eds.) Medical Mycology Lea & Febiger. Philadelphia London. 1992: 464-513.
108. Pine L. Histoplasma antigens: their production, purification and uses. Contrib Microbiol Immunol 1977;3:138-168
109. Zancopé-Oliveria RM, Bragg SL, Hurst SF, Peralta JM, Reiss E. Evaluation of cation exchange chromatography for the isolation of M glycoprotein from histoplasmin J Med Vet Mycol 1993;31:29-41.
110. Reiss E, Knowles JB, Bragg SL, Kaufman L. Monoclonal antibodies against the M-protein and carbohydrate antigens of histoplasmin characterized by the enzyme-linked immunoelectrotransfer blot method. Infect Immun 1986; 53: 540-546.
111. Kamel SM, Wheat U, Garten ML, Bartlett MS, Tansey MR, Tewan RP. Production and characterization of murine monoclonal antibodies to Histoplasma capsulatum yeast cell antigens. Infect Immun 1989; 57: 896-901.
112. Hamilton AJ, Bartholomew MA, Fenelon LE, Figueroa J, Hay RJ. A murine monoclonal antibody exhibiting high species specificity for Histoplasma capsulatum var. capsulatum. J Gen Microbiol 1990; 136:331-335.
113. Hamilton AJ, Bartholomew MA, Fenelon L, Figueroa J, Hay RJ. Preparation of monoclonal antibodies that differentiate between Histoplasma capsulatum variant capsulatum and H. capsulatum variant duboisii. Trans R Soc Trop Med Hyg 1990; 84: 425-428.
114. Jeavons L, Hunt L, Hamilton A Immunochemical studies of heat-shock protein 80 of Histoplasma capsulatum J Med Vet Mycol 1994; 32: 47-57
115. Wheat LJ, Kohler R, Tewari R. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986; 314: 83-88
116. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991; 115: 936-941.
117. Fojtasek MF, Kamel S, Karimi S, Connolly-Stringfield P, Wheat LJ. Monoclonal antibodies for detection of Histoplasma capsulatum variety capsulatum antigen in patients with histoplasmosis. Serodiag Immunother Infect Dis 1993; 5: 181-185
118. Gómez BL, Figueroa JI, Hamilton AJ, et al. Development of a novel antigen detection test for histoplasmosis. J Clin Microbiol 1997; 35: 2618-2622.
119. Brummer E, Castan̈eda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993; 6:89-117.
120. Mendes Giannini MJS, Del Negro GB, Siqueira AM. Serodiagnosis. In: Franco M, Da Silva Lacaz C. Restrepo A (Eds.) Paracoccidioidomycosis. Boca Raton, CRC Press, 1994: 345-363.
121. Aparecida M, Shikanai-Yasuda MA, Poncio Mendes R, Barraviera B, Mendes Giannini MJS. Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment. J Clin Microbiol 1998; 36: 1723-1728.
122. Figueroa JI, Hamilton AJ, Bartholomew MA, Harada T, Fenelon L, Hay RJ. Preparation of species-specific murine monoclonal antibodies against yeast phase of Paracoccidioides brasiliensis. J Clin Microbiol 1990; 28: 1766-1769.
123. Camargo ZP, Gesztesi JL, Saraiva EC, Taborda CP, Vicentini AP, Lopes, JD. Monoclonal antibody capture enzyme immunoassay for detection of Paracoccidioides brasiliensis antibodies in paracoccidioidomycosis. J Clin Microbiol 1994; 32: 2377-2381
124. Straus AH, Freymuller E, Travassos LR, Takahashi HK. Immunochemical and subcellular localisation of the 43 kDa glycoprotein antigen of Paracoccidioides brasiliensis with monoclonal antibodies. J Med Vet Mycol 1996; 34: 181-186.
125. Gesztesi JL, Puccia R, Travassos LR, et al. Monoclonal antibodies against the 43,000 Da glycoprotein from Paracoccidioides brasiliensis modulate laminm-mediated fungal adhesion to epithelial cells and pathogenesis. Hybridoma 1996; 15: 415-422
126. Figueroa JI, Hamiltom AJ, Allen MH, Hay R. Isolation and partial characterization of a Paracoccidioides brasiliensis 58 kDa extracellular glycoprotein which is recognized by human immune sera. Trans R Soc Trop Med Hyg 1995; 89: 566-572.
127. Figueroa JI, Hamilton A, Allen M, Hay R. Immunohistochemical detection of a novel 22-to 25-kDa glycoprotein of Paracoccidioides brasiliensis in biopsy material and partial characterization by using species-specific monoclonal antibodies J Clin Microbiol 1994; 32: 1566-1574.
128. Gómez BL, Figueroa JI, Hamilton AJ, et al. Use of monoclonal antibodies in diagnosis of paracoccidioidomycosis: new strategies for detection of circulating antigens. J Clin Microbiol 1997, 35: 3278-3283.
129. Gómez BL, Figueroa JI, Hamilton AJ, et al. Antigenemia in paracoccidioidomycosis: detection of the 87 kDa determinant in patients during and after antifungal treatment. J Clin Microbiol 1998; submitted